Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine
- PMID: 7649968
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine
Abstract
Drug development in psychiatry has evolved from a process dependent on chance discovery to one based on rationally targeting specific mechanisms of action believed to be important in the pathophysiology underlying psychiatric syndromes. Antidepressant pharmacotherapy is the first area to have substantially benefited from this evolution. Serotonin selective reuptake inhibitors (SSRIs) were the first class of psychiatric medications developed based on such molecular targeting. Nefazodone is a new antidepressant that combines blockade of the serotonin-2 receptor with serotonin uptake inhibition. Perhaps as a result of this dual action, nefazodone caused fewer complaints of nervousness (e.g., agitation, anxiety), insomnia, and tremors and a higher incidence of confusion, dizziness, and vision disturbance than do other advanced generation antidepressants based on several different ways of assessing the relative incidence of these adverse effects. Reports of sexual dysfunction on nefazodone and bupropion treatment were lower than on treatment with other recently released antidepressants.
Similar articles
-
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.J Affect Disord. 1998 Dec;51(3):237-54. doi: 10.1016/s0165-0327(98)00222-5. J Affect Disord. 1998. PMID: 10333980 Review.
-
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x. Br J Clin Pharmacol. 1997. PMID: 9205822 Free PMC article.
-
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.J Clin Psychiatry. 2001 Apr;62(4):256-60. J Clin Psychiatry. 2001. PMID: 11379839
-
Evaluating the tolerability of the newer antidepressants.J Nerv Ment Dis. 1999 Feb;187(2):96-101. doi: 10.1097/00005053-199902000-00005. J Nerv Ment Dis. 1999. PMID: 10067949
-
[New antidepressive agents].Union Med Can. 1995 Nov;124(3):8-13. Union Med Can. 1995. PMID: 8560639 Review. French. No abstract available.
Cited by
-
Panic Attack Precipitated by Tegaserod plus Fluoxetine.Clin Drug Investig. 2005;25(5):355-7. doi: 10.2165/00044011-200525050-00010. Clin Drug Investig. 2005. PMID: 17532675 No abstract available.
-
Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.Int Clin Psychopharmacol. 2018 Sep;33(5):249-254. doi: 10.1097/YIC.0000000000000225. Int Clin Psychopharmacol. 2018. PMID: 29864037 Free PMC article. Clinical Trial.
-
Sertraline. A pharmacoeconomic evaluation of its use in depression.Pharmacoeconomics. 1996 Oct;10(4):409-31. doi: 10.2165/00019053-199610040-00009. Pharmacoeconomics. 1996. PMID: 10184609 Review.
-
Evaluation of Arterial Stiffness in Depression Patients.Alpha Psychiatry. 2023 Sep 1;24(5):193-199. doi: 10.5152/alphapsychiatry.2023.221099. eCollection 2023 Sep. Alpha Psychiatry. 2023. PMID: 38105785 Free PMC article.
-
Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridization.ACS Chem Neurosci. 2011 Jun 8;2(9):544-552. doi: 10.1021/cn200044x. ACS Chem Neurosci. 2011. PMID: 21966587 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical